Home Cart 0 Sign in  
X

[ CAS No. 612-62-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 612-62-4
Chemical Structure| 612-62-4
Chemical Structure| 612-62-4
Structure of 612-62-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 612-62-4 ]

Related Doc. of [ 612-62-4 ]

Alternatived Products of [ 612-62-4 ]

Product Details of [ 612-62-4 ]

CAS No. :612-62-4 MDL No. :MFCD00006741
Formula : C9H6ClN Boiling Point : -
Linear Structure Formula :- InChI Key :OFUFXTHGZWIDDB-UHFFFAOYSA-N
M.W : 163.60 Pubchem ID :11928
Synonyms :

Calculated chemistry of [ 612-62-4 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.75
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.37 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.11
Log Po/w (XLOGP3) : 2.71
Log Po/w (WLOGP) : 2.89
Log Po/w (MLOGP) : 2.42
Log Po/w (SILICOS-IT) : 3.13
Consensus Log Po/w : 2.65

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.23
Solubility : 0.0954 mg/ml ; 0.000583 mol/l
Class : Soluble
Log S (Ali) : -2.63
Solubility : 0.38 mg/ml ; 0.00232 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.31
Solubility : 0.00807 mg/ml ; 0.0000493 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.39

Safety of [ 612-62-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 612-62-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 612-62-4 ]
  • Downstream synthetic route of [ 612-62-4 ]

[ 612-62-4 ] Synthesis Path-Upstream   1~36

  • 1
  • [ 612-62-4 ]
  • [ 7486-35-3 ]
  • [ 772-03-2 ]
YieldReaction ConditionsOperation in experiment
99% With tetrakis(triphenylphosphine) palladium(0) In toluene for 1.5 h; Reflux A solution of 2-chloroquinoline (1 g, 6.11 mmol) and vinyl tributyl tin (2.69 mL, 9.17 mmol) in toluene (30 mL) was treated with Pd(PPh3)4 (0.706 g, 0.611 mmol) and heated to reflux for 1.5 h. The reaction mixture was concentrated and the resulting material was purified directly by gradient elution on silica gel (0 to 25percent EtOAc in hexanes) to afford the title compound as a colorless oil (941 mg, 99percent). LRMS m/z (M+H) 156.1 found, 156.2
99% With tetrakis(triphenylphosphine) palladium(0) In toluene for 1.5 h; Reflux A solution of 2-chloroquinoline (1 g, 6.11 mmol) and vinyl tributyl tin (2.69 mL, 9.17 mmol) in toluene (30 mL) was treated with Pd(PPh3)4 (0.706 g, 0.611 mmol) and heated to reflux for 1.5 h.
The reaction mixture was concentrated and the resulting material was purified directly by gradient elution on silica gel (0 to 25percent EtOAc in hexanes) to afford the title compound as a colorless oil (941 mg, 99percent).
All spectral data matched literature values.
LRMS m/z (M+H) 156.1 found, 156.2 required. (1 .)
74% With tetrakis(triphenylphosphine) palladium(0) In toluene at 125℃; for 1 h; Inert atmosphere 1 2- vinylquinoline (1-2) 2-chloroquinoline (1-1) (1.00 g, 6.1 mmol) in toluene (25 mL) was sparged with N2 gas for 5 min, and tributyl(vinyl)stannane (2.52 g, 2.33 mL, 8.0 mmol) and tetrakis(triphenylphosphine)palladium (0.353 g, 0.31 mmol) were added. The mixture was heated at 125 °C for 1 h, then cooled and concentrated in vacuo. The residue was suspended in CH2C12 (20 mL) and purified by silica gel flash column chromatography (80 g cartridge), eluting with 0-30percent EtOAc/hexanes over 20 min. The fractions containing the desired product (1-2) were pooled, and after solvent removal in vacuo, 700 mg (74percent) of a clear oil were obtained. LC/MS: m/z (M+H) = 156.0.
Reference: [1] Patent: WO2013/28590, 2013, A1, . Location in patent: Page/Page column 33; 34
[2] Patent: EP2714041, 2016, B1, . Location in patent: Paragraph 0111
[3] Patent: WO2013/74390, 2013, A1, . Location in patent: Page/Page column 34
[4] Organic Letters, 2000, vol. 2, # 4, p. 433 - 436
[5] Patent: EP2621926, 2017, B1,
  • 2
  • [ 612-62-4 ]
  • [ 772-03-2 ]
Reference: [1] Journal of the American Chemical Society, 2012, vol. 134, # 20, p. 8428 - 8431
[2] Chemical Communications, 2016, vol. 52, # 19, p. 3770 - 3772
  • 3
  • [ 612-62-4 ]
  • [ 2005-43-8 ]
Reference: [1] European Journal of Organic Chemistry, 2002, # 24, p. 4181 - 4184
[2] Tetrahedron, 2005, vol. 61, # 6, p. 1407 - 1411
  • 4
  • [ 67-66-3 ]
  • [ 95-53-4 ]
  • [ 91-22-5 ]
  • [ 120-72-9 ]
  • [ 612-62-4 ]
  • [ 612-59-9 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 5
  • [ 67-66-3 ]
  • [ 100-61-8 ]
  • [ 612-62-4 ]
  • [ 612-59-9 ]
  • [ 19493-45-9 ]
  • [ 25836-11-7 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 6
  • [ 67-66-3 ]
  • [ 121-69-7 ]
  • [ 91-22-5 ]
  • [ 612-62-4 ]
  • [ 612-59-9 ]
  • [ 25836-11-7 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 7
  • [ 67-66-3 ]
  • [ 100-61-8 ]
  • [ 612-62-4 ]
  • [ 612-59-9 ]
  • [ 19493-45-9 ]
  • [ 25836-11-7 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 8
  • [ 67-66-3 ]
  • [ 100-61-8 ]
  • [ 612-62-4 ]
  • [ 19493-45-9 ]
  • [ 25836-11-7 ]
  • [ 100-47-0 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 9
  • [ 612-62-4 ]
  • [ 124-41-4 ]
  • [ 6931-16-4 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 6, p. 1125 - 1129
[2] Journal of Organic Chemistry, 2007, vol. 72, # 4, p. 1341 - 1346
[3] European Journal of Medicinal Chemistry, 2010, vol. 45, # 4, p. 1657 - 1662
[4] Chemische Berichte, 1882, vol. 15, p. 335
[5] Journal of the American Chemical Society, 1983, vol. 105, p. 1204
[6] Australian Journal of Chemistry, 2003, vol. 56, # 9, p. 913 - 916
  • 10
  • [ 612-62-4 ]
  • [ 3315-60-4 ]
  • [ 91-22-5 ]
  • [ 6931-16-4 ]
  • [ 50-00-0 ]
Reference: [1] Journal of the American Chemical Society, 1982, vol. 104, # 7, p. 1979 - 1986
[2] Journal of the American Chemical Society, 1982, vol. 104, # 7, p. 1979 - 1986
  • 11
  • [ 67-56-1 ]
  • [ 612-62-4 ]
  • [ 124-41-4 ]
  • [ 6931-16-4 ]
Reference: [1] Chemische Berichte, 1882, vol. 15, p. 335
  • 12
  • [ 612-62-4 ]
  • [ 15793-77-8 ]
YieldReaction ConditionsOperation in experiment
71% With hydrazine hydrate In ethanol for 16 h; Reflux 21.0 g (128.4 mmol) of 2-chloroquinoline are initially charged in 210 ml of ethanol. 64.3 g (1.3 mol) of hydrazine hydrate are added, and the mixture is stirred under reflux for 16 h. The mixture is then cooled to 0° C., and the solid formed is filtered off and washed with a little ethanol. The product is initially air-dried and then dried under high vacuum.Yield: 14.5 g (71percent of theory)LC-MS (Method 1): Rt=1.95 min; MS (ESIpos): m/z=160 [M+H]+;1H-NMR (400 MHz, DMSO-d6): δ=8.08 (br. s, 1H), 7.87 (d, 1H), 7.63 (d, 1H), 7.57-7.43 (m, 2H), 7.16 (t, 1H), 6.85 (d, 1H), 4.35 (br. s, 2H).
Reference: [1] Patent: US2012/264704, 2012, A1, . Location in patent: Page/Page column 17
[2] Journal of the Chemical Society, 1913, vol. 103, p. 1981
[3] Journal of the Indian Chemical Society, 1981, vol. 58, p. 840 - 843
[4] Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2006, vol. 65, # 2, p. 463 - 466
[5] Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, 2007, vol. 66, # 4-5, p. 972 - 975
[6] European Journal of Medicinal Chemistry, 2011, vol. 46, # 10, p. 5021 - 5033
[7] Medicinal Chemistry Research, 2013, vol. 22, # 2, p. 782 - 793
[8] Polyhedron, 2013, vol. 54, p. 39 - 46
[9] Journal of Solution Chemistry, 2017, vol. 46, # 8, p. 1575 - 1595
[10] European Journal of Medicinal Chemistry, 2018, vol. 143, p. 1463 - 1473
[11] Zeitschrift fur Naturforschung - Section B Journal of Chemical Sciences, 2018, vol. 73, # 11, p. 885 - 893
  • 13
  • [ 612-62-4 ]
  • [ 7803-57-8 ]
  • [ 15793-77-8 ]
YieldReaction ConditionsOperation in experiment
82% for 2 h; Reflux A suspension of 2-chloroquinoline (1.50 g,9.17 mmol) in hydrazine monohydrate (3 mL, 61.85 mmol) wasstirred under reflux for 2 h. The orange solid formed was collectedby filtration, washed with 100 mL of water and dried in vacuo. C9H9N3 (159.19): calcd. C 67.90, H 5.70, N26.40; found C 67.50, H 5.64, N 26.30.
Reference: [1] European Journal of Inorganic Chemistry, 2013, # 1, p. 80 - 90
  • 14
  • [ 612-62-4 ]
  • [ 15793-77-8 ]
  • [ 100146-17-6 ]
Reference: [1] Chemische Berichte, 1900, vol. 33, p. 1885
  • 15
  • [ 612-62-4 ]
  • [ 95-92-1 ]
  • [ 4491-33-2 ]
Reference: [1] Advanced Synthesis and Catalysis, 2017, vol. 359, # 15, p. 2699 - 2704
  • 16
  • [ 612-62-4 ]
  • [ 75-00-3 ]
  • [ 124-38-9 ]
  • [ 91-22-5 ]
  • [ 4491-33-2 ]
Reference: [1] Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1981, vol. 35, # 3, p. 185 - 192
  • 17
  • [ 612-62-4 ]
  • [ 91-22-5 ]
  • [ 4491-33-2 ]
Reference: [1] Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1981, vol. 35, # 3, p. 185 - 192
  • 18
  • [ 612-62-4 ]
  • [ 108-20-3 ]
  • [ 108-18-9 ]
  • [ 73776-25-7 ]
Reference: [1] Patent: US4592866, 1986, A,
[2] Patent: US4705853, 1987, A,
  • 19
  • [ 612-62-4 ]
  • [ 73776-25-7 ]
Reference: [1] Patent: US6228871, 2001, B1,
  • 20
  • [ 612-62-4 ]
  • [ 124-38-9 ]
  • [ 73776-25-7 ]
Reference: [1] Tetrahedron Asymmetry, 2004, vol. 15, # 24, p. 3919 - 3928
[2] Journal of Medicinal Chemistry, 1989, vol. 32, # 9, p. 2178 - 2199
  • 21
  • [ 612-62-4 ]
  • [ 13067-94-2 ]
  • [ 4225-86-9 ]
YieldReaction ConditionsOperation in experiment
54%
Stage #1: at 0 - 20℃; for 1 h;
Stage #2: With sodium carbonate In water
Pure H2SO4 was added onto 1 equiv of 29 at 0 °C. 3 equiv of 65percent HNO3 were then added dropwise and the reaction mixture was stirred at rt for 1 h. After the reaction mixture was poured into water, the solution was neutralized with Na2CO3 and extracted twice with dichloromethane. The organic layer was washed with water, dried over anhydrous Na2SO4 and evaporated in vacuo.Compound 30 was obtained, after purification by column chromatography (eluent: cyclohexane-ethyl acetate 8:2), as a white solid in 54percent yield; mp 152 °C, Lit: 149 °C [40]. 1H NMR (200 MHz, CDCl3) δ: 7.52-7.56 (d, J = 8.6 Hz, 1H), 7.60-7.68 (m, 1H), 8.02-8.11 (m, 2H), 8.20 (d, J = 8.6 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 124.6 (CH), 124.9 (CH), 125.8 (CH), 127.6 (C), 131.8 (CH), 138.6 (CH), 139.0 (C), 147.3 (C), 153.6 (C).Compound 31 was obtained, after purification by column chromatography (eluent: cyclohexane-ethyl acetate 8:2), as a pale yellow solid in 14percent yield; mp 134 °C, Lit: 133-134 °C [41]. 1H NMR (200 MHz, CDCl3) δ: 7.63 (d, J = 9.2 Hz, 1H), 7.80-7.88 (m, 1H), 8.34 (d, J = 8.5 Hz, 1H), 8.40 (dd, J = 1.1 and 7.7 Hz, 1H), 8.99 (d, J = 9.2 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 119.9 (C), 124.9 (CH), 125.4 (CH), 128.8 (CH), 134.9 (CH), 135.5 (CH), 145.4 (C), 148.0 (C), 152.5 (C).
50% With sulfuric acid; nitric acid In water at 0 - 20℃; for 2 h; General procedure: H2SO4 (98percent) was added onto 1 equiv. of the quinoline derivatives, cooled with an ice bath. 5 equiv. of 65percent HNO3 were then added dropwise at 0 °C and the reaction mixture was stirred at rt for 1–4 h. The reaction mixture was successively poured into ice, neutralized with NaOH and extracted three times with dichloromethane. The organic layer was washed with water, dried over anhydrous Na2SO4 and evaporated in vacuo. The crude residue was purified by chromatography on silica gel using adapted eluent and recrystallized if necessary to give compounds 1, 4, 6, 12, 15, 17 and 18. 8-nitroquinoline 1 (C9H6N2O2) was purified by chromatography on silica gel using dichloromethane as an eluent, separated from its 5-nitro isomer and isolated to yield a pale yellow solid (35percent, 2.7 mmol, 470 mg).
Reference: [1] European Journal of Medicinal Chemistry, 2012, vol. 54, p. 75 - 86
[2] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 135 - 152
[3] Journal of Medicinal Chemistry, 2012, vol. 55, # 20, p. 8603 - 8614
[4] Journal fuer Praktische Chemie (Leipzig), 1916, vol. <2> 93, p. 379
[5] Journal of the American Chemical Society, 2017, vol. 139, # 44, p. 15576 - 15579
  • 22
  • [ 612-62-4 ]
  • [ 13067-94-2 ]
YieldReaction ConditionsOperation in experiment
19% at 0 - 40℃; for 0.833333 h; A solution of nitric acid (16 mL) and sulfuric acid (8 mL) was added over period of 20 min to a solution of 2-chloroquinoline (61.1 mmol) in sulfuric acid (150 mL) at 0 °C. The reaction mixture was heated at 40 °C for 30 min and was quenched with ice water (800 mL). The precipitated solids were collected by filtration and purified by Flash chromatography (20/1 petroleum ether/ethyl acetate) to provide 2-chloro-5-nitroquinoline in 19percent yield as a yellow solid.
19% at 0 - 40℃; 20: Synthesis of 2-oxo-l,2-dihydroquinoline-5-sulfonyl chloride.1. Synthesis of 2-chloro-5-nitroquinoline.A solution of nitric acid (16 mL) and sulfuric acid (8 mL) was added over period of 20 min to a solution of 2-chloroquinoline (61.1 mmol) in sulfuric acid (150 mL) at 0 0C. The reaction mixture was heated at 40 0C for 30 min and was quenched with ice water (800 mL). The precipitated solids were collected by filtration and purified by Flash chromatography (20/1 petroleum ether/ethyl acetate) to provide 2-chloro-5-nitroquinoline in 19percent yield as a yellow solid.
19% at 0 - 40℃; 1. Synthesis of 2-chloro-5-nitroquinoline.A solution of nitric acid (16 mL) and sulfuric acid (8 mL) was added over period of 20 min to a solution of 2-chloroquinoline (61.1 mmol) in sulfuric acid (150 mL) at 0 0C. The reaction mixture was heated at 40 0C for 30 min and was quenched with ice water (800 mL). The precipitated solids were collected by filtration and purified by Flash chromatography (20/1 petroleum ether/ethyl acetate) to provide 2-chloro-5-nitroquinoline in 19percent yield as a yellow solid.
Reference: [1] Patent: WO2009/23844, 2009, A2, . Location in patent: Page/Page column 108
[2] Patent: WO2010/21797, 2010, A1, . Location in patent: Page/Page column 71
[3] Patent: WO2010/24980, 2010, A1, . Location in patent: Page/Page column 89
[4] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 22, p. 6559 - 6578,20
[5] Bioorganic and Medicinal Chemistry, 2012, vol. 20, # 22, p. 6559 - 6578
  • 23
  • [ 612-62-4 ]
  • [ 13067-94-2 ]
  • [ 4225-86-9 ]
YieldReaction ConditionsOperation in experiment
54%
Stage #1: at 0 - 20℃; for 1 h;
Stage #2: With sodium carbonate In water
Pure H2SO4 was added onto 1 equiv of 29 at 0 °C. 3 equiv of 65percent HNO3 were then added dropwise and the reaction mixture was stirred at rt for 1 h. After the reaction mixture was poured into water, the solution was neutralized with Na2CO3 and extracted twice with dichloromethane. The organic layer was washed with water, dried over anhydrous Na2SO4 and evaporated in vacuo.Compound 30 was obtained, after purification by column chromatography (eluent: cyclohexane-ethyl acetate 8:2), as a white solid in 54percent yield; mp 152 °C, Lit: 149 °C [40]. 1H NMR (200 MHz, CDCl3) δ: 7.52-7.56 (d, J = 8.6 Hz, 1H), 7.60-7.68 (m, 1H), 8.02-8.11 (m, 2H), 8.20 (d, J = 8.6 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 124.6 (CH), 124.9 (CH), 125.8 (CH), 127.6 (C), 131.8 (CH), 138.6 (CH), 139.0 (C), 147.3 (C), 153.6 (C).Compound 31 was obtained, after purification by column chromatography (eluent: cyclohexane-ethyl acetate 8:2), as a pale yellow solid in 14percent yield; mp 134 °C, Lit: 133-134 °C [41]. 1H NMR (200 MHz, CDCl3) δ: 7.63 (d, J = 9.2 Hz, 1H), 7.80-7.88 (m, 1H), 8.34 (d, J = 8.5 Hz, 1H), 8.40 (dd, J = 1.1 and 7.7 Hz, 1H), 8.99 (d, J = 9.2 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ: 119.9 (C), 124.9 (CH), 125.4 (CH), 128.8 (CH), 134.9 (CH), 135.5 (CH), 145.4 (C), 148.0 (C), 152.5 (C).
50% With sulfuric acid; nitric acid In water at 0 - 20℃; for 2 h; General procedure: H2SO4 (98percent) was added onto 1 equiv. of the quinoline derivatives, cooled with an ice bath. 5 equiv. of 65percent HNO3 were then added dropwise at 0 °C and the reaction mixture was stirred at rt for 1–4 h. The reaction mixture was successively poured into ice, neutralized with NaOH and extracted three times with dichloromethane. The organic layer was washed with water, dried over anhydrous Na2SO4 and evaporated in vacuo. The crude residue was purified by chromatography on silica gel using adapted eluent and recrystallized if necessary to give compounds 1, 4, 6, 12, 15, 17 and 18. 8-nitroquinoline 1 (C9H6N2O2) was purified by chromatography on silica gel using dichloromethane as an eluent, separated from its 5-nitro isomer and isolated to yield a pale yellow solid (35percent, 2.7 mmol, 470 mg).
Reference: [1] European Journal of Medicinal Chemistry, 2012, vol. 54, p. 75 - 86
[2] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 135 - 152
[3] Journal of Medicinal Chemistry, 2012, vol. 55, # 20, p. 8603 - 8614
[4] Journal fuer Praktische Chemie (Leipzig), 1916, vol. <2> 93, p. 379
[5] Journal of the American Chemical Society, 2017, vol. 139, # 44, p. 15576 - 15579
  • 24
  • [ 612-62-4 ]
  • [ 4225-86-9 ]
YieldReaction ConditionsOperation in experiment
64% at 0 - 40℃; for 0.833333 h; A solution of nitric acid (16 mL) and sulfuric acid (8 mL) was added over period of 20 min to a solution of 2-chloroquinoline (61.1 mmol) in sulfuric acid (150 mL) at 0 °C. The reaction mixture was heated at 40 °C for 30 min and was quenched with ice water (800 mL). The precipitated solids were collected by filtration and purified by Flash chromatography (20/1 petroleum ether/ethyl acetate) to provide 2-chloro-8-nitroquinoline in 64percent yield as a yellow solid.
64% at 0 - 40℃; Intermediate 23: Synthesis of 2-oxo-l,2-dihydroquinoline-8-sulfonyl chloride.1. Synthesis of 2-chloro-8-nitroquinoline.A solution of nitric acid (16 mL) and sulfuric acid (8 mL) was added over period of 20 min to a solution of 2-chloroquinoline (61.1 mmol) in sulfuric acid (150 mL) at 0 0C. The reaction mixture was heated at 40 0C for 30 min and was quenched with ice water (800 mL). The precipitated solids were collected by filtration and purified by Flash chromatography (20/1 petroleum ether/ethyl acetate) to provide 2-chloro-8-nitroquinoline in 64percent yield as a yellow solid.
64% at 0 - 40℃; Intermediate 23: Synthesis of 2-oxo-l,2-dihydroquinoline-8-suIfonyl chloride. 1. Synthesis of 2-chloro-8-nitroquinoline.A solution of nitric acid (16 mL) and sulfuric acid (8 mL) was added over period of 20 min to a solution of 2-chloroquinoline (61.1 mmol) in sulfuric acid (150 mL) at 0 0C. The reaction mixture was heated at 40 0C for 30 min and was quenched with ice water (800 mL). The precipitated solids were collected by filtration and purified by Flash chromatography (20/1 petroleum ether/ethyl acetate) to provide 2-chloro-8-nitroquinoline in 64percent yield as a yellow solid.
38% at 0 - 20℃; General Procedure 15: 2-Chloro-8-nitroquinoline (Intermediate 24)Conc. H2SO4 was added slowly to 2-chloroquinoline (1.0 g, 6.13 mmol), followed by portionwise addition of potassium nitrate (800 mg, 7.97 mmol) at 0° C. The mixture was allowed to warm to room temperature overnight. After completion of the reaction (monitored by TLC and HPLCMS), the solution was poured slowly over ice, and the precipitate was extracted with EtOAc. The organic phase was washed with brine and concentrated in vacuo. The crude residue was purified by column chromatography with n-hexane/EtOAC (17:3) as the eluent to give the title compound (450 mg, 38percent).MW: 208.61HPLCMS (4.5 min): [m/z]: 209

Reference: [1] Patent: WO2009/23844, 2009, A2, . Location in patent: Page/Page column 112
[2] Patent: WO2010/21797, 2010, A1, . Location in patent: Page/Page column 75-76
[3] Patent: WO2010/24980, 2010, A1, . Location in patent: Page/Page column 93; 94
[4] ChemMedChem, 2018,
[5] Australian Journal of Chemistry, 2003, vol. 56, # 1, p. 39 - 44
[6] Journal of the American Chemical Society, 2017, vol. 139, # 44, p. 15576 - 15579
[7] Patent: US2012/214803, 2012, A1, . Location in patent: Page/Page column 126
  • 25
  • [ 612-62-4 ]
  • [ 100-51-6 ]
  • [ 116249-87-7 ]
Reference: [1] Advanced Synthesis and Catalysis, 2017, vol. 359, # 10, p. 1649 - 1655
  • 26
  • [ 612-62-4 ]
  • [ 3492-64-6 ]
  • [ 116249-87-7 ]
Reference: [1] Journal of the American Chemical Society, 1952, vol. 74, p. 4452
  • 27
  • [ 612-62-4 ]
  • [ 100-53-8 ]
  • [ 116249-87-7 ]
Reference: [1] Patent: US2185182, 1937, ,
[2] Journal of Organic Chemistry, 1981, vol. 46, p. 5300 - 5304
  • 28
  • [ 110-85-0 ]
  • [ 612-62-4 ]
  • [ 4774-24-7 ]
YieldReaction ConditionsOperation in experiment
100% at 140℃; for 2 h; To a solution formed by dissolving 4.31 g of anhydrous piperazine in 30 ml of ethylene glycol, 818 mg of 2-chloroquinoline was added, and stirred at 140°C for 2 hours. After cooling, saturated aqueous sodium hydrogencarbonate solution was added, and the system was extracted with chloroform. The organic layer was dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was purified on silica gel column chromatography (chloroform: methanol = 2:1) to provide 1.09 g (100percent) of 2-piperazin-1-ylquinoline. 1H-NMR(CDCl3)δ:7.89(d,J=9.2Hz,1H),7.70(d,J=8.4Hz, 1H), 7.59(dd,J=1.5Hz,8.0Hz,1H), 7.53(ddd,J=1.5Hz,7.0Hz,8.4Hz,1H),7.26~7.22(m,1H), 6.97(d,J=9.2Hz,1H),3.70(t,J=5.0Hz,4H),3.01(t,J=5.0Hz,4H) Mass,m/e:213(M+),145(base)To a solution formed by dissolving 4.31 g of anhydrous piperazine in 30 ml of ethylene glycol, 818 mg of 2-chloroquinoline was added, and stirred at 140°C for 2 hours. After cooling the reaction mixture, saturated aqueous sodium hydrogencarbonate solution was added, followed by extraction with chloroform. The organic layer was dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was purified on silica gel column chromatography (chloroform : methanol = 2:1) to provide 1.09 g (100percent) of 2-piperazin-1-ylquinoline. 1H-NMR(CDCl3)δ:7.89(d,J=9.2Hz,1H),7.70(d,J=8.4Hz,1H), 7.59(dd,J=1.5Hz,8.0Hz,1H), 7.53(ddd,J=1.5Hz,7.0Hz,8.4Hz,1H),7.26.similar.7.22(m,1H), 6.97(d,J=9.2Hz,1H),3.70(t,J=5.0Hz,4H),3.01(t,J=5.0Hz,4H) Mass,m/e:213(M+),145(base)
55% for 2 h; Heating / reflux A mixture of 2-chloroquinoline (2 g; 0.0122 mole ; 1EQ) and piperazine (10.5 g; 0.122 mole ; 10 eq. ) in DMSO (5 ml) was refluxed for 2h. The reaction mixture was cooled to RT, diluted with H20 (20 mi) and extracted with DCM (3X20ML). The organic phases were combined, dried (NA2SO4) and concentrated in vacuo. The crude product was purified by SPE cartridge (Si, 10G), ELUTING with a gradient of 0 to 1percent of MeOH in DCM affording the title compound (1.42 g; yield 55percent). MS; (ES) m/z: 214.3 [MH+]. C13H15N3 requires 213.28. 'H NMR (300MHZ, CDCI3) 5 : 7.85 (d, 1H), 7.74 (d, 1H), 7.97-7. 45 (t/d, 2H), 7.2 (t, 1 H), 6.9 (d, 1H), 3.67 (t, 4H), 2.98 (t, 4H).
52.2% for 6 h; Reflux A mixture of 2-chloroquinoline (2.0 g, 0.012 mol) and piperazine(2.1 g 0.024 mol) in toluene (15 mL) was refluxed stirring for 6 h.The reaction mixture was placed in an ice bath, diluted with 15 mLof water, acidified with concentrated HCl and filtrated. 40 mL ofwater was added to the filtrate and organic phase was separated.The aqueous phase was washed with ethyl ether and alkalized withsolid NaOH. The solid free base was separated by filtration andcrystallized from the mixture of ethanol and water to give compound(7).The title compound was isolated as a white powder. Yield: 52.2percent1.361 g, m.p. 81e84 C (lit. 81e83 C [23]).
36% for 24 h; Heating / reflux Step l0.20 g (2.45 mmol) of piperazine was dissolved in 15 mL of isopropanol in a dried round flask provided with nitrogen gas, 2-chloroquinoline 0.20 g (1.2 mmol) was added thereto, and the mixture was refluxed with stirring for 24 hrs. After adding water thereto, the reaction was extracted with ethyl acetate. The formed organic layer was washed with a saturated NaCl solution, dried over anhydrous magnesium sulfate, <n="48"/>and concentrated under a reduced pressure. The resulting residue was subjected to silica gel column chromatography (dichlorornethane:methanol=4:l) to obtain 2-(piperazin-l-yl)quinoline (yield: 36percent).

Reference: [1] Patent: EP1724267, 2006, A1, . Location in patent: Page/Page column 35; 68
[2] Journal of Medicinal Chemistry, 2010, vol. 53, # 21, p. 7549 - 7563
[3] Journal of Pharmaceutical Sciences, 1992, vol. 81, # 1, p. 99 - 103
[4] Chemical and Pharmaceutical Bulletin, 2001, vol. 49, # 10, p. 1314 - 1320
[5] Patent: WO2004/46124, 2004, A1, . Location in patent: Page 41
[6] European Journal of Medicinal Chemistry, 2015, vol. 98, p. 221 - 236
[7] Patent: WO2008/153325, 2008, A1, . Location in patent: Page/Page column 45-46
[8] Polish Journal of Chemistry, 2001, vol. 75, # 1, p. 71 - 78
[9] Bulletin de la Societe Chimique de France, 1929, vol. &lt;4&gt; 45, p. 1177,1178
[10] Patent: US6043247, 2000, A,
[11] Molecules, 2008, vol. 13, # 10, p. 2426 - 2441
[12] Acta Poloniae Pharmaceutica - Drug Research, 2018, vol. 75, # 4, p. 891 - 901
  • 29
  • [ 612-62-4 ]
  • [ 73568-25-9 ]
YieldReaction ConditionsOperation in experiment
92% With n-butyllithium; diisopropylamine In tetrahydrofuran; <i>N</i>-methyl-acetamide; acetic acid EXAMPLE 7
2-Chloro-3-quinolinecarboxaldehyde
To a solution of 0.46 mL (3.30 mmol) of diisopropylamine in 8 mL of THF at 0° C. was added 1.53 mL (3.30 mmol) of n-BuLi dropwise.
After 20 min the solution was cooled to -78° C. and 2-chloroquinoline (491 mg, 3.0 mmol) was added neat.
The mixture was stirred at -78° C. for 30 min, then dimethylformamide (0.39 mL, 5.04 mmol) was added dropwise and the reaction mixture was stirred an additional 30 min at this temperature.
After quenching at -78° C. with glacial acetic acid (1 mL), the mixture was warmed to room temperature and diluted with ether (30 mL).
The organic phase was washed with saturated NaHCO3 solution (10 mL) and brine (10 mL), and was dried over MgSO4.
Concentration afforded 2-chloro-3-quinolinecarboxaldehyde (530 mg, 92percent) as a light yellow solid (mp 145°-149 ° C.), which was used directly in the next step without further purification.
Recrystallization from ethyl acetate afforded the pure compound as light yellow needles: mp 149°-150° C. (mp 148°-149° C. reported in Meth-Cohn, O.; Narhe, B.; Tarnowski, B. J. Chem. Soc. Perkin Trans. I 1981, 1520.).
1 H NMR (300 MHz, CDCl3) δ 10.57 (s, 1H), 8.77 (s, 1H), 8.08 (d, 1H, J=9 Hz), 8.0 (d, 1H, J=9 Hz), 7.90 (t, 1H, J=9 Hz), 7.67 (t, 1H, J=9 Hz); IR (nujol) 1685, 1575, 1045, 760, 745 cm-1.
92% With n-butyllithium; diisopropylamine In tetrahydrofuran; <i>N</i>-methyl-acetamide; acetic acid EXAMPLE 7
2-Chloro-3-quinolinecarboxaldehyde
To a solution of 0.46 mL (3.30 mmol) of diisopropylamine in 8 mL of THF at 0° C.
Was added 1.53 mL (3.30 mmol) of n-BuLi dropwise.
After 20 min the solution was cooled to -78° C. and 2-chloroquinoline (491 mg, 3.0 mmol) was added neat.
The mixture was stirred at -78° C. for 30 min, then dimethylformamide (0.39 mL, 5.04 mmol) was added dropwise and the reaction mixture was stirred an additional 30 min at this temperature.
After quenching at -78° C. with glacial acetic acid (1 mL), the mixture was warmed to room temperature and diluted with ether (30 mL).
The organic phase was washed with saturated NaHCO3 solution (10 mL) and brine (10 mL), and was dried over MgSO4.
Concentration afforded 2-chloro-3-quinolinecarboxaldehyde (530 mg, 92percent) as a light yellow solid (mp 145°-149 ° C.), which was used directly in the next step without further purification.
Recrystallization from ethyl acetate afforded the pure compound as light yellow needles: mp 149°-150° C. (mp 148°-149° C. reported in Meth-Cohn, O.; Narhe, B.; Tarnowski, B. J. Chem. Soc. Perkin Trans. I 1981, 1520.).
1H NMR (300 MHz, CDCl3) δ 10.57 (s, 1H), 8.77 (s, 1H), 8.08 (d, 1H, J=9 Hz), 8.0 (d, 1H, J=9 Hz), 7.90 (t, 1H, J=9 Hz), 7.67 (t, 1H, J=9 Hz); IR (nujol) 1685, 1575, 1045, 760, 745 cm-1.
Reference: [1] Patent: US5212317, 1993, A,
[2] Patent: US5162532, 1992, A,
  • 30
  • [ 612-62-4 ]
  • [ 68-12-2 ]
  • [ 73568-25-9 ]
Reference: [1] Journal of Organic Chemistry, 2015, vol. 80, # 24, p. 12509 - 12525
  • 31
  • [ 612-62-4 ]
  • [ 7461-12-3 ]
Reference: [1] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 135 - 152
[2] ChemMedChem, 2018,
  • 32
  • [ 612-62-4 ]
  • [ 128676-94-8 ]
Reference: [1] Chemical Communications, 2014, vol. 50, # 25, p. 3353 - 3355
[2] Tetrahedron, 2005, vol. 61, # 6, p. 1407 - 1411
  • 33
  • [ 612-62-4 ]
  • [ 128676-94-8 ]
  • [ 206563-13-5 ]
Reference: [1] Canadian Journal of Chemistry, 2002, vol. 80, # 6, p. 589 - 600
  • 34
  • [ 612-62-4 ]
  • [ 128676-85-7 ]
Reference: [1] Heterocycles, 2004, vol. 63, # 3, p. 631 - 639
[2] Tetrahedron, 2007, vol. 63, # 51, p. 12786 - 12790
[3] Bulletin of the Korean Chemical Society, 2016, vol. 37, # 6, p. 958 - 961
  • 35
  • [ 612-62-4 ]
  • [ 455955-27-8 ]
  • [ 124467-23-8 ]
  • [ 77119-53-0 ]
Reference: [1] Journal of Fluorine Chemistry, 2004, vol. 125, # 5, p. 661 - 671
  • 36
  • [ 612-62-4 ]
  • [ 886853-93-6 ]
Reference: [1] Journal of Organic Chemistry, 2007, vol. 72, # 4, p. 1341 - 1346
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 612-62-4 ]

Chlorides

Chemical Structure| 15679-03-5

[ 15679-03-5 ]

6-Chlorophenanthridine

Similarity: 0.92

Chemical Structure| 72093-13-1

[ 72093-13-1 ]

6-Chloro-2,3-dimethylpyridine

Similarity: 0.92

Chemical Structure| 13040-77-2

[ 13040-77-2 ]

6-Chloro-2,2'-bipyridine

Similarity: 0.88

Chemical Structure| 23616-33-3

[ 23616-33-3 ]

2-Chloro-1,6-naphthyridine

Similarity: 0.85

Chemical Structure| 43083-14-3

[ 43083-14-3 ]

2-Chloro-6-phenylnicotinonitrile

Similarity: 0.83

Related Parent Nucleus of
[ 612-62-4 ]

Quinolines

Chemical Structure| 611-35-8

[ 611-35-8 ]

4-Chloroquinoline

Similarity: 0.77

Chemical Structure| 86-98-6

[ 86-98-6 ]

4,7-Dichloroquinoline

Similarity: 0.76

Chemical Structure| 612-59-9

[ 612-59-9 ]

3-Chloroquinoline

Similarity: 0.75

Chemical Structure| 100516-88-9

[ 100516-88-9 ]

Quinolin-6-ylmethanol

Similarity: 0.71

Chemical Structure| 4113-04-6

[ 4113-04-6 ]

6-Quinolinecarboxaldehyde

Similarity: 0.70